Cargando…
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs
With the development of poly(ADP-ribose) polymerase inhibitors, the treatment of advanced ovarian cancer is changing dramatically. The purpose of this narrative review is to provide a direction for the individualization of advanced ovarian cancer treatment based on the mechanism of action of molecul...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006498/ https://www.ncbi.nlm.nih.gov/pubmed/35416600 http://dx.doi.org/10.1007/s10147-022-02163-3 |